The Evaluation of COVID-19 Booster Vaccination Results for Health

Workers at a AP Private Hospital in North Jakarta

Nadiah Tasbiha

, Stefanus Lukas

1,2

and Ida Pulina

Faculty of Pharmacy, Universitas 17 Agustus 1945 Jakarta, Indonesia

Faculty of Pharmacy, Andalas University, Padang, West Sumatra, Indonesia

Keywords: Vaccine Booster, Covid-19, Health Workers.

Abstract: Providing remedies in an effort to combat and prevent the spread of covid-19. To evaluate AEFI and

effectiveness of booster covid-19 vaccine among health workers in a private hospital. Method Hospital health

professionals x were surveyed utilizing the cross-sectional approach employing social media (WhatsApp) and

a google form platform. Convenience sampling, which must satisfy the inclusion requirements, is the

sampling approach used. In this research, The number of respondents that met the inclusion criteria reached

up to (n=102). The results of this study with validity and rehabilitation values (0.741) Health workers had

AEFI fever (54.9%), pain in the injection area (58.8%), cough (58.8), flu (9.8%), dizziness (13.7%),

drowsiness (18.6%), menstrual disorders (15.7%), x health workers exposed to covid-19 (8.8%) Significant

correlations existed between AEFI, Infection with covid-19, menstruation abnormalities following

administration of booster immunizations to hospital health workers x hospital health employees exposed to

covid-19 (8.8%) after covid vaccination, 15.7% of women reporting menstruation problems. Nine individuals

who received the third dosage of Booster and were exposed to covid-19 (8.8%) were self-isolating (100%).

Conclusion most of the patients pain in the injection area and cough after booster vaccination and only few

people got covid-19 infection after booster vaccination.

1 INTRODUCTION

The international community, including Indonesia,

uses social media to socialize with other communities

(Silalahi & Ginting, 2022).

In December 2019 in Wuhan, Hubei province of

China, it was discovered that pneumonia instances of

this sickness were not recognized to be the origin of

the disease, which rapidly spread to provinces around

China and even the world. (Romadhan et al., 2022)

Who stated that, as of 20 June 2022 at 5:40 p.m.,

there were 536,590,224 confirmed cases of COVID-

19, including 6,316,655 deaths? As of 20 June 2022,

a total of 11,912,594,538 doses of vaccination had

been administered to the community (Emerging

Infections of the Ministry of Health of the Republic

of Indonesia. 2022).

At 15:00 on April 29, 2022, there were 6,046,467

confirmed cases of COVID-19, followed by the

recovery of 5,882,062 cases (97.3%), the death of

156,240 patients (2.6%), and the occurrence of 8,165

active cases. (Emerging Infections of the Ministry of

Health, Republic of Indonesia, 2022)

Initially, the patient complained of mild,

moderate, and severe (critical) symptoms, as well as

a variety of additional complaints typical of his

patients, including fever, headache, cough, and

difficulty breathing, as well as weakness and

gastrointestinal symptoms. (Yanti, 2020) The

majority of patients have a favorable prognosis, and

only a small proportion of those in critical condition

will perish. (Lilyawati et al., 2019) It is believed that

the immune response contributes to the pathogenesis

of the disease and offers protection during its

remission. (Safira et al., 2021)

Implementing the 5M health routine, which

includes washing hands, wearing masks, maintaining

a safe distance, minimizing movement, and avoiding

crowds. In addition, there is a policy enforcing a new

routine (New Normal) of working from home (WFH)

(South et al., 2022). Then preventive measures must

still be taken, including the COVID-19 vaccine

campaign (Lebang et al., 2022). Vaccination is one

among the measures that can be taken to combat the

spread of covid-19. The application of the covid-19

vaccination is disseminated to the entire community,

Tasbiha, N., Lukas, S. and Pulina, I.

The Evaluation of COVID-19 Booster Vaccination Results for Health Workers at a AP Private Hospital in North Jakarta.

DOI: 10.5220/0011978200003582

In Proceedings of the 3rd International Seminar and Call for Paper (ISCP) UTA â

Z45 Jakarta (ISCP UTA’45 Jakarta 2022), pages 173-178

ISBN: 978-989-758-654-5; ISSN: 2828-853X

 2023 by SCITEPRESS – Science and Technology Publications, Lda. Under CC license (CC BY-NC-ND 4.0)

173

and vaccinations are administered for the prevention

and spread of the covid-19 virus, resulting in a large

number of individuals receiving the vaccine. (Dr.

Vladimir, 1967)

Vaccine is a liquid contained in the body that will

be injected into humans, who will actively create their

immunity in the body for a vaccine in order to defend

the body against virus attacks (Widjaja, 2021)

The vaccination should not be rejected because

the Covid-19 vaccine intends to protect not just the

individual but also the community as a whole, i.e., to

create herd immunity. (Digital & Conference, 2021)

CoronaVac vaccine, AstraZeneca vaccine, and

Moderna vaccine in Indonesia (Lestari et al., 2022).

According to (Ministry of Health RI, 2020), the

government has concluded that the following

vaccines would be used in the future in Indonesia:

This sort of sinovac vaccination collaborates with

government entities in Indonesia and internationally.

(Widjaja, 2021)

This type of AstraZeneca vaccination was tested

on 20,000 volunteers and was shown to have no

adverse effects when stored at room temperature.

(Widjaja, 2021).

This vaccine is a 94.5% effective vaccine

production rate Moderna type, according to the

manufacturer. moderna is a vaccine that meets the US

Food and Drug Administration's emergency usage

standards (FDA). (Widjaja, 2021).

The effectiveness of the Pfizer vaccination against

the corana virus has been demonstrated to be 95%,

and it poses no risk to human health. (Widjaja, 2021).

The government-run immunization program has no

positive and negative effects on the community.

(Sihidi et al., 2022)

2 METHODS

This study employed the Cross-Sectional research

design. Hospital x health staff were invited to

participate as volunteers by completing an online

survey. At the outset of the questionnaire, participants

were told of their readiness to serve as study

participants. Respoden will be given a questionnaire

to complete out.

2.1 Sampling Techniques

Technique of sampling utilizing Convenience

Sampling, which must meet inclusion requirements.

Sampling is conducted using non-probability

sampling with the quota sampling approach, which is

a sampling strategy that sets a certain quantity as a

target to be met in sampling data from a population.

2.2 Data Collection

Collect data in hospitals x by distributing surveys

using social media (WhatsApp) using the google form

platform. With a total of 102 answers and 24

questions, the evaluation of the results of the covid-

19 booster vaccine on health professionals in

hospitals x with a cronbach alpha value of 0.741%

will be conducted.

2.3 Sample

All health workers at Hospital X who have obtained

booster vaccinations and are willing to participate in

the study meet the inclusion criteria for this study. All

medical personnel at Hospital X who have not gotten

a booster vaccination are excluded from this study.

Health professionals that decline to participate in the

study, All Health Workers in Indonesia with cancer,

HIV/AIDS, tuberculosis, or autoimmune disease.

2.4 Population

A total of 102 health care employees were vaccinated

with a booster at Hospital X for the purpose of this

study.

2.5 Data Analysis

To determine whether there is a correlation between

the evaluation of COVID-19 vaccine results on

healthcare workers in hospitals and running the Chi-

square test, it is necessary to first analyze the data on

the distribution of the questionnaire. This can be done

with the aid of Excel software and the SPSS 2.5

application.

2.6 Ethical Consent

Ethical approval of this study with number No.47 /

KEPKUTA45JKT / EC / EXP / 07/2022.

ISCP UTA’45 Jakarta 2022 - International Seminar and Call for Paper Universitas 17 Agustus 1945 Jakarta

174

3 RESULTS AND DISCUSSIONS

Table 1: Characteristics of Respondents.

Variables Frequency Percentage

Gende

a. Man 32 31,4%

. Woman 70 68,6%

Age

a. Juveniles (18-

24)

30 29,41%

b. Adulthood (25-

45)

72 70,59%

Profession

(Occupation)

a. Nurse 55 53,9%

. Non Nurse 47 46,1%

On the basis of Table 1, we determined the

sociodemographic profile of the 102 participants in

this study, namely their gender 32 men (31.4%) and

70 women (68.6%) with adolescent age 18-24 years

30 respondents (29.41%), adulthood 25-45 years 72

respondents (70.59%), by profession (occupation) 55

respondents (53.9%) and non-nurses 47 respondents

(46.1%).

This differs with the study (Pengetahuan et al.,

2021), in which the majority of respondents were men

(51 respondents, or 51 %) and the fewest were women

(49 respondents, or 49 %). Moreover, by occupation,

there were 55 nurses (53.9%) and 47 non-nurses

(46.1%).

In accordance with a previous study (Pratama et

al., 2022), the majority of research subjects in this

study (72%) were health care professionals, such as

nurses and midwives.

Figure 1: Expose Covid-19 After Booster Vaccination.

Based on Figure 1, it can be seen that there are 9

health workers who were exposed to covid-19 after

the booster vaccine. based on different research

results from (Zaenal et al., 2020) there are 31 people

(10.8%) who are exposed to covid-19.

Table 2: AEFI After the 3rd Dose of Covid-19 Vaccination.

No. Variables Frequency and

percentage

1. Feve

56 Respondent (54.9%)

2. Pain In The

Injection

Area

60 Respondent (58.8%)

3. Cou

h 60 Respondent (58.8%)

4. Sleep

10 Respondent (9.8%)

5. Menstrual

Disorders

14 Respondent (13.7%)

6. Flu 19 Respondent (18.6%)

7. Dizzy 16 Respondent (15.7%)

Based on table 2, it was determined that AEFI was

typically experienced by all respondents of this study

who received the sinovac, astrazeneca, pfizer, and

moderna booster vaccines, and that there was AEFI

following covid-19 immunization in this study,

namely fever following covid-19 immunization

54.9%, injection area following covid-19

immunization 58.8%, cough has following covid-19

immunization 58.8%, flu has following covid-19

immunization 9.8%, dizziness has following covid-

19 immunization 13.7%, drowsiness has following

covid-19 immunization 18.6%, menstrual disorders

have following covid-19 immunization 15.7%.

According to this study, the adverse effects of the

phase I vaccine on light symptoms are 22 (17.74%),

moderate symptoms are 49 (39.51%), and severe

symptoms are 1 (0.80%), which is consistent with the

study of Safira et al. from 2021. Mild symptoms made

up 20 (16.12%) of the phase II vaccine's side effects,

while moderate symptoms made up 54 (43.54%) and

severe symptoms made up 3 (2.41%). The analysis of

the data allows us to draw the conclusion that the

drajat AEFI at Imanuel Hospital has the biggest

administration (43.54%) of the Coronavac

vaccination. In the research, 102 completely

immunized participants got questionnaires about their

experiences with vaccine adverse effects. Menstrual

abnormalities are the most frequent adverse effects of

fever and the injection site, with a frequency (yes, 16

and not 86) and percentage (yes, 13.7% and not

84.3%).

Expose

Covid-19

Yes No

The Evaluation of COVID-19 Booster Vaccination Results for Health Workers at a AP Private Hospital in North Jakarta

175

Table 3: Health Workers Exposed to Covid-19 Experience

Symptoms When Exposed to Covid-19.

No. Variables Frequency and

percentage

1. Symptoms

when exposed

to covi

Yes 9 Respondent

(8.8%)

2. Isolation at the

time of

exposure to

covi

Self-isolation 9

Respondent

(100%)

3. Loss of smell

and taste when

exposed to

covi

Yes 9 Respondent

(8.8%)

4. Difficulty

breathing when

exposed to

covi

Yes 9 Respondent

(8.8%)

5. sore throat

when exposed

to covi

Yes 9 Respondent

(8.8%)

6. fever when

exposed to

covi

Yes 9 Respondent

(8.8%)

7. Headaches

Exposed to

covi

Yes 9 Respondent

(8.8%)

8. Treatment

when exposed

to covi

Yes 9 Respondent

(8.8%)

According to Table 3, Symptoms when exposed

to covid 8.8%, Self-isolation when exposed after

100% frequency booster vaccine%, loss of smell and

sense of exposure after booster vaccination has 8.8%,

difficulty breathing after exposure after booster

vaccination has 8.8%, cough and sore throat after

exposure after booster vaccination has 8.8%, fever

after exposure after booster vaccination has 8.8%,

headache after exposure after booster vaccination has

8.8%, treatment when exposed to covid 8.8%.

This is consistent with the study's finding that the

most prevalent symptoms of COVID-19 are fever,

cough, myalgia or weariness, and shortness of breath

(Banjarnahor, 2020). other unusual signs, such as

headache and diarrhea. Fever (77%), cough (81%),

cough with phlegm (56%), headache (34%), myalgia

or weariness (52%), diarrhea (8%), and hemoptysis

(3%), are the most prevalent symptoms. Only two

individuals (3%) out of all patients admitted to the

hospital had breathing difficulties.In this instance, it

is consistent with the research (Iswanti et al., 2021)

whose findings indicated the experience of nurses

when confirmed with COVID-19 as many as 6 (six)

most critical risk factors are direct contact with

Covid-19 sufferers. (10) Whether it involves sharing

a residence or a history of visiting a region affected

by a pandemic. One of the people who are most at risk

of getting SARS-CoV-2 is the medical profession.

Table 4: The existence correlation of a between the sexes

and AEFI flu.

Percentage Frequency (%)

Variable Man Woman P-

value

Gender

of AEFI

flu after

booster

vaccine

Respondent

(23.3%)

Respondent

(41.3%)

0.005

*Chi-square

According to this study, AEFI and gender factors

are related. The booster vaccine is the difference

between gender and AEFI that is frequently received

by women compared to men who have the flu after

booster vaccination was found with men 13 people

with a frequency of 23.3% while for women it was

found with a figure of 19 people with a percentage

(41.3%) and value of 0.005 out of a total of 102

respondents whose questions have been tested using

the chi square set e test. This is consistent with the

study (Romlah & Darmayanti, 2022) in which,

following the vaccination, a small percentage of

respondents, namely 7 people (15.9%), experienced a

high fever (>390C), and half of respondents who

experienced AEFI, namely 22 people (50%)

experienced other types of AEFI such as soreness at

the injection site, flu, inhibiting menstruation,

dizziness, sore throat, pain, anosmia.

Table 5: There is a correlation between profession and

AEFI.

Frequency/Percentage (%)

Variable nurse non nurses P-

value

AEFI

profession

fever

Respondent

(69.1%)

Respondent

(38.3%)

0.002*

Professions

often

sunbathe

Yes 50

Respondent

(90.9%)

Yes 32

Respondent

(68.5%)

0.004*

Professions

in which

vaccines

are locate

Yes 48

Respondent

(87.2%)

Yes 25

Respondent

(53.2%)

0.000*

*Chi-square

ISCP UTA’45 Jakarta 2022 - International Seminar and Call for Paper Universitas 17 Agustus 1945 Jakarta

176

Based on this study, the variables have a

correlation between Profession and AEFI from a total

of 102 respondents whose questions have been tested

using the chi set testelah booster vaccine, as for the

difference between Profession and AEFI which is

widely received by nurses and non-nurses, nurses

who have a fever after booster vaccination was found

by nurses with the number 69.1% and non-nurses

found 38.3% with a p value of 0.002, Nurse

respondents frequently sunbathed were identified

with a figure of 90.9%, while non-nurses were

identified with a figure of 68.5% with a p value of

0.004, and nurse respondents had different

experiences with booster vaccinations were identified

with a figure of 87.2%, while non-nurses were

identified with a figure of 53.2% with a p value of

0.000. According to research (Romadhan et al., 2022)

the most common time of AEFI was 12 hours after

vaccination for 17.8% of respondents, with the

majority of AEFI occurring in the form of pain at the

injection site for 85.7% of respondents, or 90

respondents. The majority of responders (40%)

reported having discomfort for two days, while 22.9%

reported having pain on a scale of seven. The majority

(46.2%) of the 52 respondents with AEFI fever had a

fever that lasted 12 to 24 hours, and one respondent

(1.9%) had a fever that lasted five days. The majority

of the time, the post-vaccination temperature is

between 37.6°C and 38°C (40%).

4 CONCLUSIONS

The evaluation of covid-19 booster vaccination

results for health workers at a private hospital can

draw the conclusion from the study's findings that the

AEFI suffered by respondents who received the

booster vaccine is a common AEFI, such as fever,

pain in the injection area, cough, flu, dizziness,

drowsines. Women who worked as nurses reported

experiencing the highest AEFI following the covid

vaccination. Health workers who have been

vaccinated with the booster were still exposed to

Covid-19. There is a link between the vaccine and

AEFI, the effects of menstruation, and the exposure

of healthcare professionals to COVID-19 after

receiving the booster shot.

REFERENCES

Alyssa, M., Warinangin, M., & G. A. R. (2021). Evaluation

of monitoring of post-immunization follow-up events

(AEFI) Covid-19 vaccine (Coronavac) on health

workers at Bandar Lampung Immanuel Hospital.

Journal Of Mandala Pharmacon Indonesia, 7 (2), 251-

262.

Banjarnahor, S. (2020). Variations Of Covid-19 Symptoms

Experienced By Murni Teguh Memorial Hospital

Nurses. Indonesian Trust Health Journal, 3 (2), 360-

363. https://doi.org/10.37104/ithj.v3i2.60

Dr. dr. Soebagijo Adi Soelistijo, (2021) SPPD, K-EMD,

FINASIM, FACP, et al guidelines for the management

and Prevention of adult type 2 Diabetes Mellitus in

Indonesia. Publisher Pb. Perkeni.

Digital, I., & Conference, C. (2021). 西薗由依＊ 1 ，尾

城孝一＊ 2 ，古川雅子＊ 3 ，南山泰之＊ 4.

12(1), 187–193.

Dr. Vladimir, V. F. (1967). ④no title No Title No Title.

Gastronom a Ecuatoriana y Turismo Local., 1(69), 5–

24.

Emerging Infections Ministry of Health. (2022). Retrieved

23 June 2022, from

https://infeksiemerging.kemkes.go.id/dashboard/covid

-19

Iswanti, I., Ilmi, B., & Syafwani, M. (2021). Nurse's

Experience When Covid-19 Was Confirmed At Doctor

H Hospital. Mochammad Ansari Saleh Banjarmasin.

Syntax Idea, 3 (2), 321.

https://doi.org/10.36418/syntax-idea.v3i2.1046

Knowledge, H. A., Behavior, D. A. N., Against, M., Nissha,

V., Ray, M., Samion, M., & Lukito, A. (2021). COVID

19 pandemic prevention in Tanjung BALAI the

RELATIONSHIP BETWEEN KNOWLEDGE ,

ATTITUDE , and COMMUNITY BEHAVIOR

TOWARDS COVID 19 PANDEMIC PREVENTION

in TANJUNG BALAI CITY introduction corona Virus

2019 or known as Covid-19 appeared first . IV(I), 39-

45.

Linda, et al. (2021). synergize with the community to

accelerate the handling of covid-19 and post-flood

management. Banjarmasin University Press

Lebih, S. S. S., Nelwan, E. J., & Langi, F. L. F. G. (2022).

Public Perception Of Coronavirus Disease Vaccination

2019. Journal of Public Health, 11 (2), 171-175.

Lestari, S. P. P., Tirta, I. G. R., Kartika, R., Maheraditya,

A., & Coronavac, V. (2022). Detection of

seroconversion with RAPID ANTIBODY TEST after

COVID-19 vaccination Faculty of Medicine and Health

Sciences Warmadewa University the second wave of

COVID-19 due to the Emergency Use Authorization (

EUA ) program from the COVID-19 SARS-CoV-2

COVID-19 agency. 1(2), 73–77.

Lilyawati, S. A., Fitriani, N., & Prasetya, F. (2019).

Proceedings of Mulawarman Pharmaceuticals

Conferences. Proceedings of Mulawarman

Pharmaceuticals Conferences, April 2021, 135-138.

http://prosiding.farmasi.unmul.ac.id/index.php/mpc/art

icle/view/416/399

Nugroho, S. A., & Hidayat, I. N. (2021). Covid-19 Vaccine

Effectiveness And Safety : A Reference Study. Journal

Of Professional Nursing, 9(2), 61-107.

https://doi.org/10.33650/jkp.v9i2.2767

The Evaluation of COVID-19 Booster Vaccination Results for Health Workers at a AP Private Hospital in North Jakarta

177

Primary, T. D., Hasbie, N. F., Farich, A., & Yulyani, V.

(2022). Analysis of factors related to the incidence of

Covid-19 infection in health workers. 16(2), 172–181.

Romadhan, A., Primary, L., Magglin, C., Jufrie, H., Fatima,

N., Nathaniel, M., & Bakhtiar, R. (2022). HEALTH

WORKERS IN SAMARINDA. 9(1), 1–13.

Romney, S. N., & Darmayanti, D. (2022). Post-

immunization follow-up events (AEFI) Covid-19

vaccine. Holistic Health Journal, 15(4), 700-712.

https://doi.org/10.33024/hjk.v15i4.5498

South, K., Jakarta, M., & Siahaan, F. M. (2022). ISSN

2798-3641 (Online). 2(2).

Sihidi, I. T., Romadhan, A. A., & Fitrah, D. (2022). Journal

of political Issues vaccines and public sentiment : an

analysis. Journal of Political Issues, 3(2), 107-114.

Silalahi, N., & Ginting, G. L. (2022). Analysis of public

sentiment in the use of Sinovac vaccine by applying

Term frequency –Inverse Document frequency (TF-

IDF) algorithm and description method. Josh, 3(3),

206-217. https://doi.org/10.47065/josh.v3i3.1441

Widjaja, G. (2021). Understanding vaccination in the

community in Jakarta. Journal Ofcommunity

Dedication, 1(1), 41-53.

https://adisampublisher.org/index.php/pkm/article/vie

w/32/28

Yanti, B. (2020). Journal of Health Science diversity of

clinical manifestations in Coronavirus Disease 2019.

Journal of Health Science, V (II), 47-54.

https://www.ejournalwiraraja.com/index.php/JIK/articl

e/view/997

ISCP UTA’45 Jakarta 2022 - International Seminar and Call for Paper Universitas 17 Agustus 1945 Jakarta

178